| Zugriffe | |
|---|---|
| A Randomized, Double‐Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moderate to Severe Rheumatoid Arthritis | 76 |
| Oktober 2024 | November 2024 | Dezember 2024 | Januar 2025 | Februar 2025 | März 2025 | April 2025 | |
|---|---|---|---|---|---|---|---|
| A Randomized, Double‐Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moderate to Severe Rheumatoid Arthritis | 1 | 1 | 2 | 1 | 1 | 7 | 0 |
| Zugriffe | |
|---|---|
| 2020_Burmester_etal.pdf | 73 |
